Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Sebastiani

Showing results (101-110 of 210) with videos related to

Pageof 21
Sort By:
Canadian Liver Journal|August 22, 2022
Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)Brian Conway, Dan Smyth, Réjean Thomas, et al.
Journal of Hepatology|July 10, 2010
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale studyGiada Sebastiani, Diego Tempesta, Giovanna Fattovich, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitisJens Marquardt, Riku Ota, Giada Sebastiani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2026
Clinical Outcomes and Non-Invasive Testing in Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic ReviewHannes Hagström, Chris Hellmund, Jeffrey V Lazarus, et al.
Plos One|January 31, 2018
Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infectionAmine Benmassaoud, Peter Ghali, Joseph Cox, et al.
Antiviral Research|October 3, 2012
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapySilvia Mirandola, Giada Sebastiani, Cristina Rossi, et al.
AIDS (London, England)|October 3, 2020
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIVJovana Milic, Valentina Menozzi, Filippo Schepis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2020
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency VirusAdriana Cervo, Jovana Milic, Giovanni Mazzola, et al.
Crohn'S & Colitis 360|February 27, 2023
Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel DiseasesDana Kablawi, Faisal Aljohani, Chiara Saroli Palumbo, et al.
Scientific Reports|July 8, 2025
Machine learning models using non-invasive tests & B-mode ultrasound to predict liver-related outcomes in metabolic dysfunction-associated steatotic liver diseaseHeather Mary-Kathleen Kosick, Chris McIntosh, Chinmay Bera, et al.
Pageof 21

Showing results (101-110 of 210) with videos related to

Sort By:
Pageof 21
Canadian Liver Journal|August 22, 2022
Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)Brian Conway, Dan Smyth, Réjean Thomas, et al.
Journal of Hepatology|July 10, 2010
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale studyGiada Sebastiani, Diego Tempesta, Giovanna Fattovich, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitisJens Marquardt, Riku Ota, Giada Sebastiani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2026
Clinical Outcomes and Non-Invasive Testing in Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic ReviewHannes Hagström, Chris Hellmund, Jeffrey V Lazarus, et al.
Plos One|January 31, 2018
Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infectionAmine Benmassaoud, Peter Ghali, Joseph Cox, et al.
Antiviral Research|October 3, 2012
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapySilvia Mirandola, Giada Sebastiani, Cristina Rossi, et al.
AIDS (London, England)|October 3, 2020
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIVJovana Milic, Valentina Menozzi, Filippo Schepis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2020
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency VirusAdriana Cervo, Jovana Milic, Giovanni Mazzola, et al.
Crohn'S & Colitis 360|February 27, 2023
Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel DiseasesDana Kablawi, Faisal Aljohani, Chiara Saroli Palumbo, et al.
Scientific Reports|July 8, 2025
Machine learning models using non-invasive tests & B-mode ultrasound to predict liver-related outcomes in metabolic dysfunction-associated steatotic liver diseaseHeather Mary-Kathleen Kosick, Chris McIntosh, Chinmay Bera, et al.
Pageof 21